Quark Venture partners GF Securities of China. The two companies agrees to collaborate and to operate in Canada. They will solely focus in life sciences and biotechnology.
Biotechnology
Breaking News
Amgen Inc on Wednesday said its new type of treatment for a deadly form of leukemia would cost about $178,000 when it becomes available on Thursday, which would make it one of the world's most expensive cancer drugs.
U.S. stock index futures pointed to very slight gains at the open on Tuesday, with investors finding few reasons to buy after a rally in the previous session that took the S&P 500 index above 2,000 for the first time.
Renowned Middle Eastern scientist Hayat Sindi called for more investments in the field of science and technology to foster inventive spirit and innovation.
A biotech company wants to raise US$125 million through its IPO.
Aeolus enters agreement with accredited investors on private placement financing worth of 3.2 million dollars
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- IBM Set to Acquire HashiCorp in Possible Mega-Deal, Stock Skyrockets 24% to $6.1 Billion Valuation
- Stellantis Plans to Lay Off Unspecified Number of Workers at US Factories in Coming Months
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- New Biden Administration Rule to Grant 4 Million Workers Overtime Pay; Here's What You Need to Know!
- Oracle CEO Reveals Plans to Relocate World Headquarters to Nashville, Citing the City’s Reputation as Well-Established Health Center
